Pricing-driven top-line surge
A 42% year-over-year increase in average selling prices across the portfolio was the primary driver of the 31% revenue growth, despite the revenue headwind from the Refining Solutions divestiture.
ALBEMARLE CORP is expected to release its Q3 2026 10-Q filing on November 3, 2026, after market close. Last quarter: Albemarle Corporation delivered a standout Q2 FY2026 with revenue up 31% and net income turning sharply positive on a 42% pricing gain in lithium, while executing a major balance-sheet deleveraging through divestitures.
EPS Estimate
$3.49
Revenue Estimate
$1.68B
Analyst consensus from Finnhub and Financial Modeling Prep. Actual results posted within minutes of the SEC filing on the ALB page.
Drawn from management commentary in the Q2 2026 10-Q:
A 42% year-over-year increase in average selling prices across the portfolio was the primary driver of the 31% revenue growth, despite the revenue headwind from the Refining Solutions divestiture.
The sale of the Refining Solutions business closed in Q1 FY2026, removing $215.3 million in net sales and $32.9 million in adjusted EBITDA from the year-ago comparison; proceeds were used to redeem senior notes and reduce leverage.
A fire at the Talison joint venture’s third chemical grade plant (CGP3) will keep spodumene output below normal until the second half of 2026, though integrated production and Wodgina volume are mitigating the impact.
Revenue
$1.74B
+31.08% YoY
EPS (Diluted)
$3.52
+2300.00% YoY
Gross Margin
33.9%
+19.1 pts YoY
Operating Income
$452.94M
+853.02% YoY
Add ALB to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.